Skip to content

Author

Shengnan Zhao

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Multi-Target Pharmacological Mechanisms of Cannabidiol in Breast, Colorectal, and Lung Cancer: An Integrated Network Pharmacology and Molecular Docking Study

Combining pooled cancer-associated network pharmacology with co-crystallized ligand benchmarking suggests that CBD may exert its biological activity through coordinated modulation of multiple cancer-related signaling pathways rather than a single molecular target.

Marlon C. Mallillin, A. Chattopadhyay, Irish Mhel C. Mitra et al. · 0 citations
Review Sep 2026

Clinical Pharmacokinetics and Disposition of Imrecoxib

Current evidence is limited by small, mainly single-dose studies, predominantly Chinese populations, and the absence of validated exposure-response relationships integrating imrecoxib, M1, and M2, and the absence of validated exposure-response relationships integrating imrecoxib, M1, and M2.

Sheng-Nan Zhao, Charlie Li, Marlon C. Mallillin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.